An integrated biosensing framework that treats readout reliability as an explicit engineering objective rather than a post hoc correction problem, and establishes a generalizable strategy for constructing trustworthy POCT systems in which chemical signal generation and digital interpretation are co-designed.
By linking molecular-level recognition with computational signal interpretation, this review highlights the advantages and limitations of artificial intelligence-integrated biosensors for next-generation point-of-care diagnostics, continuous health monitoring, and personalized healthcare applications.
Özge Altıntaş, Adil Denizli· Electronics· 0 citations
A review of recent progress in AI-assisted biosensor development highlights how AI can link molecular design, device engineering, and signal interpretation to accelerate the development of next-generation biosensors.
Yunseon Han, Haebin Jo, Minyoung Ju et al.· Biosensors· 0 citations
Functionalized design is presented as an application‐backward, cross‐scale framework that links clinical needs and biomarker–matrix constraints with recognition chemistry, biointerfaces, functional materials, transduction architectures, calibration, data interpretation, manufacturability, and validation.
Yanan Li, Yang Zhou, Meng Yang et al.· Advanced Materials & Technol...· 0 citations
This review summarizes the evolution of SERS-based bacterial detection from fundamental nanomaterials to integrated clinical diagnostic platforms and reveals a research shift from maximizing electromagnetic enhancement toward overcoming matrix effects in clinical samples and ensuring robustness.
Yueqi Yang, Jing Li, Xinyi Hu et al.· Biosensors· 0 citations
A single-pot electrochemical sensing platform that enables rapid and ultrasensitive quantitative detection of AD biomarkers directly from untreated blood or plasma within 20 min of collection, without sample preparation, washing, or using additional reagents is reported.
Xuewei Du, Taoping Zhang, Zhongzhong Wan et al.· ACS Sensors· 0 citations
This review highlights the comparison of two electrochemical platforms—antibody-based platform (immunosensor) and aptamer-based platform (aptasensor)—developed from 2021 to 2026 for four important BC biomarkers, human epidermal growth factor receptor 2 (HER2), carbohydrate antigen 15-3 (CA 15-3), carcinoembryonic antigen (CEA), and circulating microRNA-21.
Manasa T L, Rajeshkumar Upadhyaya, D. H B· International Journal For Mu...· 0 citations
A new method, called CW-Net, translates the reasoning process of an autonomous vehicle’s AI system into understandable concepts that explain its behavior.